AbelsonTaylor, Aimmune Therapeutics, and Seres Therapeutics
C. diff Endless Sequels Journal Ad
Since recurrent C. diff is a dire condition that keeps patients coming back, the idea of endless horror-movie sequels is a perfect fit. Shining a light on the role of the microbiome in changing the ending of the same predictable plot, this campaign shapes how people think about C. diff.
AbelsonTaylor Team Members:
Brad Graetz, Group Creative Director
Lincoln Cairns, Associate Creative Director, Copy
Michael Gedraitis, Associate Creative Director, Art
Paula Lemperis, Copy Supervisor
Andrea Park, Art Supervisor
